Clinical Trials for Heterozygous Familial Hypercholesterolemia

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

NCT ID: NCT06958315

The INSPIRE Study is a clinical trial looking at a medication called inclisiran (Leqvio®) for patients with certain heart and blood vessel conditions, specifically atherosclerotic vascular disease ...

Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia

NCT ID: NCT06634160

The STEATO-FH study is researching how common liver fat buildup, known as steatosis, is in people who have a condition called heterozygous familial hypercholesterolemia. This condition means that i...

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

NCT ID: NCT06568471

This clinical trial is studying a new medication called HST101, which is designed to help lower cholesterol levels in patients with high cholesterol and related heart conditions. Specifically, the ...

Long-term Follow-up of Participants Dosed with an Investigational Gene Editing Therapy for Cardiovascular Disease

NCT ID: NCT06112327

A Study of VERVE-102 in Patients with Familial Hypercholesterolemia or Premature Coronary Artery Disease

NCT ID: NCT06164730

This clinical trial is studying a new treatment called VERVE-102 for patients with a genetic condition known as heterozygous familial hypercholesterolemia (HeFH) or those with early heart disease d...